Do Patients Benefit from a Trial of Corticosteroids at the End of Life?
Crossref DOI link: https://doi.org/10.1007/s11864-022-00977-x
Published Online: 2022-04-01
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yennurajalingam, Sriram
Bruera, Eduardo
Text and Data Mining valid from 2022-04-01
Version of Record valid from 2022-04-01
Article History
Accepted: 11 March 2022
First Online: 1 April 2022
Declarations
:
: Dr. Yennurajalingam declares that he has no conflict of interest. Dr. Bruera declares that he has no conflict of interest.